March 16, 2018
Rose
Opternative, a Chicago-based purveyor of online and mobile refractive eye exams, received a warning letter from the FDA last fall. The October 30 warning letter was only recently made public by the agency.
from MobiHealthNews http://ift.tt/2IuWoBN
March 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Transforming healthcare through technology will increase buy-in from staff, patients- Reflexion Health’s virtual platform to power non-profit’s senior rehabilitation program
- Digital health deals: CareFirst makes strategic investment in Sharecare and more
- CES 2018: Running list of digital health products
- Another $15M for Spirosure's respiratory analysis device
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment